The Current Opinion journal series is comprised of up-to-date, peer-reviewed scientific journals, that provide scientists with an easy way to remain informed of all the latest developments within their fields of interest. They are available individually or as a set on a subscription basis.
For information about institutional subscriptions and free trials visit our library information pages or contact institutions@biomedcentral.com. For corporate and personal online subscriptions please email ts.custserv.emea@thomson.com.
There are 4 titles in the series, each covering a specific area of Pharmaceutical R&D
- Current Opinion in Drug Discovery & Development is published bimonthly and focuses on the chemical aspects of drug discovery and development.
- Current Opinion in Investigational Drugs is published monthly and delivers systematic and comprehensive coverage of the following therapeutic areas:
- Anti-infectives
- Anti-inflammatory, immune-meditated and gastrointestinal
- Cardiovascular, renal and metabolic
- Central and peripheral nervous system
- Oncological
- Current Opinion in Molecular Therapeutics is published bimonthly and covers the broad field of molecular medicine, including viral and non-viral gene therapy, oligonucleotides, peptide therapeutics, antibody approaches, molecular vaccines, and the technologies underlying genomics and proteomics.
- IDrugs: The Investigational Drugs Journal brings you up to the minute reports on breakthroughs in research via unparalleled coverage of scientific meetings.
